Eli Lilly and Co (CHIX:LLYZ) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:LLYZ Eli Lilly and Co CHIX:LLYZ
34 GF Score
Price CHF885.00
GF Value CHF1,167.79
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eli Lilly and Co Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:LLYZ
34GF Score
Eli Lilly and Co CHIX:LLYZ
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (CHIX:LLYZ) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of CHF885.00 is trading 24.2% below its estimated GF Value™ of CHF1,167.79. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for CHIX:LLYZ:

  • Interest Received:
  • GF Value™: CHF1,167.79 vs. price of CHF885.00 (24.2% below fair value)
  • GF Score™: 34/100 with 5 warning signs

No single metric tells the full story. See the CHIX:LLYZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
34GF Score

Get the complete analysis for CHIX:LLYZ

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF885.00
Price
CHF1,167.79
GF Value